PL Development’s First ANDA Adds Ibuprofen Manufacturing As Growth Driver
This article was originally published in The Pink Sheet Daily
FDA approves private label firm PL Developments’ ANDA to make store brand ibuprofen in its manufacturing facility, giving the firm more control over its supply chain and possible market share gains against national brands and other generics providers, says President Evan Singer.
You may also be interested in...
HBW Executive Decisions: Perrigo Americas, Nutraceutical International Helm Changes, ABC Farnsworth Award, More
Myos Rens hires Eric LeGrand as special advisor for sports nutrition; Perrigo Consumer Americas chief Jeff Needham will be succeeded by Rich Sorota; Nutraceutical International appoints Monty Sharma to replace Chad Clawson at the helm; American Botanical Council’s Farnsworth Award goes to Rachel Mata; and Herbalife’s John Agwunobi will be chairman as well as CEO.